NYSE:NSPR
InspireMD Inc Stock News
$1.92
+0.0650 (+3.51%)
At Close: Apr 25, 2024
InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference
08:59am, Wednesday, 03'rd Apr 2024
TEL AVIV, Israel and MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today anno
InspireMD to Report Fourth Quarter and Full-Year 2023 Financial Results and Provide Corporate Business Update on Wednesday, March 6th
07:00am, Wednesday, 28'th Feb 2024
-Conference call and webcast to be held at 8:30 a.m. EST- TEL AVIV, Israel and MIAMI, Feb. 28, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention St
InspireMD's (NSPR) CE Mark Recertification to Boost CGuard EPS
12:31pm, Monday, 05'th Feb 2024
InspireMD's (NSPR) CE Mark Recertification under MDR is likely to help the company boost the CGuard EPS for carotid artery revascularization care along with advancing with new products.
Down -24.61% in 4 Weeks, Here's Why InspireMD, Inc. (NSPR) Looks Ripe for a Turnaround
11:17am, Thursday, 23'rd Nov 2023
InspireMD, Inc. (NSPR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings est
InspireMD to Participate in Upcoming November Investor Conferences
08:00am, Thursday, 02'nd Nov 2023
TEL AVIV, Israel and MIAMI, Fla., Nov. 02, 2023 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for treatment of carotid artery dis
InspireMD to Report Third Quarter 2023 Financial Results and Provide Corporate Business Update on Monday, November 6th
09:21am, Monday, 30'th Oct 2023
-Conference call and webcast to be held at 8:30 a.m. EST- TEL AVIV, Israel and MIAMI, Oct. 30, 2023 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention St
InspireMD to Report Second Quarter 2023 Financial Results and Provide Corporate Business Update on Tuesday, August 8th
08:00am, Tuesday, 25'th Jul 2023
-Conference call and webcast to be held at 8:30 a.m. EDT- TEL AVIV, Israel and MIAMI, July 25, 2023 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention St
InspireMD Announces May 16, 2023 as New Date for First Quarter 2023 Results Conference Call and Webcast
04:05pm, Friday, 12'th May 2023
- Conference call and webcast to be held at 8:30 a.m. EDT - TEL AVIV, Israel, May 12, 2023 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent Syste
InspireMD to Report Fourth Quarter and Full-Year 2022 Financial Results on March 30, 2023, and Provide a Corporate Business Update
08:00am, Thursday, 02'nd Mar 2023
-Conference call and webcast to be held at 8:30 a.m. EDT-
InspireMD, Inc. (NSPR) Q3 2022 Earnings Call Transcript
12:56pm, Tuesday, 08'th Nov 2022
InspireMD, Inc. (NASDAQ:NSPR ) Q3 2022 Earnings Conference Call November 8, 2022 8:30 AM ET Company Participants Chuck Padala - IR, LifeSci Advisors Marvin Slosman - CEO Craig Shore - CFO Conference C
InspireMD to Report Third Quarter 2022 Financial Results on November 8, 2022, and Provide Corporate Business Update
08:00am, Tuesday, 25'th Oct 2022
-Conference call and webcast to be held at 8:30 a.m. EDT- -Conference call and webcast to be held at 8:30 a.m. EDT-
InspireMD, Inc. (NSPR) CEO Marvin Slosman on Q2 2022 Results - Earnings Call Transcript
02:50pm, Tuesday, 09'th Aug 2022
InspireMD, Inc. (NASDAQ:NSPR ) Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Chuck Padala - Investor Relations Marvin Slosman - Chief Executive Officer Craig Shore -
InspireMD to Report Second Quarter 2022 Financial Results on August 9, 2022, and Provide Corporate Business Update
08:00am, Tuesday, 02'nd Aug 2022
- Conference call and webcast to be held at 8:30 a.m. EDT -
5 Stocks To Watch For June 6, 2022
04:18am, Monday, 06'th Jun 2022
Some of the stocks that may grab investor focus today are: Wall Street expects Science Applications International Corporation (NYSE: SAIC) to report quarterly earnings at $1.77 per share on revenue of
InspireMD, Inc. (NSPR) CEO Marvin Slosman on Q1 2022 Results - Earnings Call Transcript
01:36pm, Tuesday, 10'th May 2022
InspireMD, Inc. (NASDAQ:NSPR ) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants Chuck Padala - Investor Relations Marvin Slosman - Chief Executive Officer Craig Shore - Ch